[HTML][HTML] Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC
V Bafiti, E Thanou, S Ouzounis, A Kotsakis… - Cancers, 2024 - mdpi.com
Abstract Background and Objective: Lung cancer, the second most prevalent cancer
globally, poses significant challenges in early detection and prognostic assessment. Despite …
globally, poses significant challenges in early detection and prognostic assessment. Despite …
MALAT1 and BCYRN1 lncRNAs expression in patients with breast cancer from Northwest Iran
Introduction Abnormally expressed lncRNAs in cancer tissues can potentially play as
biomarkers for cancer diagnosis, prognosis, and treatment. This study aimed to assess the …
biomarkers for cancer diagnosis, prognosis, and treatment. This study aimed to assess the …
[HTML][HTML] Propofol orchestrates long non-coding RNAs in MCF7 cells, unraveling new avenues for breast cancer intervention
Long non-coding RNAs (lncRNAs) play a dynamic role in gene expression regulation and
serve as potential therapeutic targets in breast cancer. The anticancer effect of propofol, an …
serve as potential therapeutic targets in breast cancer. The anticancer effect of propofol, an …
Hsa_circYARS interacts with miR-29a-3p to up-regulate IREB2 and promote laryngeal squamous cell carcinoma progression
Z Guo, Y Zhao, N Guo, M Xu, X Wang - Discover Oncology, 2024 - Springer
Objective This study was to investigate the carcinogenic capacity of circYARS in laryngeal
squamous cell carcinoma (LSCC) and to reveal its potential mechanism as a competitive …
squamous cell carcinoma (LSCC) and to reveal its potential mechanism as a competitive …